Annual Meeting 2025, held from August 29 to September 1 in Madrid, Spain, showcased a sweeping array of advancements in the ...

Novo Nordisk announced that the European Medicines Agency (EMA) has approved an update to the label for Rybelsus (oral ...

Despite missing the primary endpoint, aTyr Pharma still sees a future for the drug as it plans further FDA discussions.

Cadrenal Therapeutics has acquired eXIthera Pharmaceuticals' portfolio of Factor XIa inhibitors to expand its anticoagulation ...

The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

MSD has scrapped its UK expansion plans due to the government's lack of investment in the life sciences sector.

Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m, aimed at propelling its gene therapy ...

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 ...

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...